What is the latest ASTERDM stock price?
The latest stored price for ASTERDM is Rs 761.55 as of 2026-08-21.
gimli
ASTERDM stock AI analysis
ASTERDM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ASTER DM QUALITY CARE LTD is a mid-cap stock in Healthcare. This Gimli page shows the latest available ASTERDM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹761.55
1W return
-7.39%
1M return
-6.38%
3M return
+0.30%
6M return
+20.73%
1Y return
+25.41%
Market cap
₹39,367.30 cr
PE
119.30
PB
8.14
ROE
+7.60%
ROCE
+7.24%
RSI
32.14
Turnover
₹266.07 cr
Why it can matter in screens
- Momentum: ASTERDM is below 50DMA, above 200DMA; RSI is 32.14.
- Returns: 1D -0.54%, 1W -7.39%, 1M -6.38%, 3M +0.30%, 1Y +25.41%.
- Trend levels: 52W high ₹891.30, 52W low ₹711.30, off high -14.56%.
- Liquidity: latest turnover is ₹266.07 cr; volume vs 20D is +0.69%.
- Valuation/profitability: PE 119.30, PB 8.14, ROE +7.60%, ROCE +7.24%.
- Growth: 3Y sales CAGR -26.51%, 3Y profit CAGR +117.00%.
Quick Answers
Is ASTERDM above its 50DMA and 200DMA?
ASTERDM is below 50DMA, above 200DMA. The latest 50DMA is 804.94 and the latest 200DMA is 695.27.
What are ASTERDM PE, ROE and ROCE?
ASTERDM has PE 119.30, ROE +7.60%, and ROCE +7.24% in Gimli's latest available snapshot.
How has ASTERDM performed recently?
ASTERDM has returned -6.38% over 1 month, +0.30% over 3 months, and +25.41% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 1,310.68 cr | 178.58 cr | 16.06 cr | 0.31 |
| 2026-03-31 | 1,182.38 cr | 260.58 cr | 140.17 cr | 2.72 |
| 2025-12-31 | 1,185.76 cr | 202.18 cr | 52.45 cr | 1.02 |
| 2025-09-30 | 1,225.00 cr | 278.09 cr | 121.31 cr | 2.13 |
| 2025-06-30 | 1,077.87 cr | 230.43 cr | 85.52 cr | 1.67 |
| 2025-03-31 | 1,000.34 cr | 186.92 cr | 79.02 cr | 1.59 |
| 2024-12-31 | 1,049.81 cr | 194.86 cr | 56.79 cr | 1.14 |
| 2024-09-30 | 1,086.44 cr | 252.38 cr | 96.84 cr | 1.94 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 4,069.42 cr | 833.31 cr | 5,377.83 cr | 107.98 |
| 2024-03-31 | 3,638.19 cr | 1,355.03 cr | 129.28 cr | 2.60 |
| 2023-03-31 | 2,951.80 cr | 1,061.05 cr | 424.91 cr | 8.54 |
| 2022-03-31 | 10,253.28 cr | 1,534.45 cr | 525.99 cr | 10.58 |
| 2021-03-31 | n/a | n/a | n/a | nan |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-03-31 | 6,606.38 cr | 164.59 cr | 2,017.77 cr | 3,651.45 cr |
| 2024-03-31 | 17,991.31 cr | 82.23 cr | 1,383.75 cr | 5,030.11 cr |
| 2023-03-31 | 14,881.20 cr | 378.53 cr | 5,700.30 cr | 4,860.46 cr |
| 2022-03-31 | 12,546.24 cr | 343.37 cr | 4,907.13 cr | 4,482.62 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-03-31 | 425.05 cr | 68.32 cr | n/a |
| 2024-03-31 | 157.81 cr | -647.77 cr | n/a |
| 2023-03-31 | 1,833.98 cr | 986.10 cr | n/a |
| 2022-03-31 | 1,314.04 cr | 766.07 cr | n/a |
| 2021-03-31 | n/a | n/a | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-07-13 | +53.72% | +10.31% | +16.48% | +15.93% | +19.49% | +18.17% |
| 2026-06-30 | +40.39% | +10.53% | +27.65% | +26.70% | +21.42% | +40.66% |
| 2026-03-31 | +40.39% | +17.18% | +27.57% | +26.45% | +14.62% | +40.66% |
| 2025-12-31 | +40.39% | +18.46% | +26.12% | +24.60% | +14.79% | +40.66% |
| 2025-09-30 | +40.39% | +18.72% | +26.32% | +24.89% | +14.33% | +40.66% |
| 2025-06-30 | +40.39% | +19.64% | +25.28% | +23.87% | +14.44% | +40.67% |
| 2025-04-29 | +40.38% | +23.62% | +24.63% | +23.46% | +11.11% | +40.67% |
| 2025-03-31 | +41.89% | +21.66% | +24.59% | +23.29% | +11.60% | +40.67% |
| 2024-12-31 | +41.88% | +22.62% | +22.91% | +22.24% | +12.31% | +98.87% |
| 2024-09-30 | +41.88% | +23.85% | +20.91% | +20.17% | +13.06% | +98.87% |
| 2024-06-30 | +41.88% | +27.08% | +16.35% | +15.72% | +14.38% | +98.87% |
| 2024-03-31 | +41.88% | +33.48% | +13.70% | +13.59% | +10.59% | +98.87% |
| 2023-12-31 | +41.88% | +41.00% | +7.15% | +7.11% | +9.60% | +98.87% |
| 2023-09-30 | +41.88% | +40.21% | +7.64% | +7.54% | +9.85% | +98.87% |
| 2023-06-30 | +41.88% | +38.81% | +8.63% | +8.56% | +10.26% | +98.87% |
| 2023-03-31 | +41.88% | +38.64% | +8.94% | +8.88% | +10.12% | +98.87% |
| 2022-12-31 | +37.88% | +42.49% | +8.93% | +8.88% | +10.26% | +10.44% |
| 2022-09-30 | +37.88% | +11.78% | +8.99% | +8.94% | +40.91% | +10.44% |
| 2022-06-30 | +37.88% | +0.00% | +21.10% | n/a | n/a | +10.44% |
| 2022-03-31 | +37.88% | +0.00% | +19.67% | n/a | n/a | +10.44% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 456,449.49 cr | 37.677543 | +15.50% | +15.99% |
| DIVISLAB | DIVI S LABORATORIES LTD | 228,223.36 cr | 78.319614 | +18.37% | +42.62% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 165,719.79 cr | 75.983398 | +17.33% | +34.25% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 124,992.04 cr | 63.823550 | +21.03% | +9.67% |
| CIPLA | CIPLA LTD | 115,693.19 cr | 34.304976 | +10.25% | -10.08% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 112,698.21 cr | 22.474914 | +17.93% | +13.61% |
| LUPIN | LUPIN LIMITED | 100,669.80 cr | 14.727517 | +34.34% | +12.19% |
| MANKIND | MANKIND PHARMA LIMITED | 98,418.27 cr | 47.977550 | +13.18% | -8.31% |
Try these prompts
- Analyze ASTER DM QUALITY CARE with valuation, momentum and industry peers
- Compare ASTERDM with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare ASTERDM with other Healthcare stocks
Data snapshot: 2026-08-21. Not investment advice.